Pancreatic Cancer Research

ResearcherNantong UniversityActive in the last 2 years

Xudong Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3522-3971; OpenAlex author ID A5100348142. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
20
Papers, trials and grants by year

2015: 2 papers · 2016: 2 papers · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 2 papers · 2022: none · 2023: none · 2024: 2 papers

Papers 8

  1. Dual rectification of metabolism abnormality in pancreatic cancer by a programmed nanomedicine. Co-author DOI 10.1038/s41467-024-54963-y↗
  2. Integrated ctDNA Methylation Profiling of P2RX1, CBFA2T3, and CERS4 as Pancreatic Ductal Adenocarcinoma Biomarkers: Identification and Mechanistic Insights Co-author DOI 10.21203/rs.3.rs-4982255/v1↗
  3. Penetration Cascade of Size Switchable Nanosystem in Desmoplastic Stroma for Improved Pancreatic Cancer Therapy. Co-author DOI 10.1021/acsnano.0c08860↗
  4. A novel methylation signature predicts inferior outcome of patients with PDAC. Last author DOI 10.18632/aging.202347↗
  5. Elevated expression of growth-regulated oncogene-alpha in tumor and stromal cells predicts unfavorable prognosis in pancreatic cancer. Co-author DOI 10.1097/md.0000000000004328↗
  6. Correlation Between RAB27B and p53 Expression and Overall Survival in Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000000453↗
  7. High expression of RAB27A and TP53 in pancreatic cancer predicts poor survival. Co-author DOI 10.1007/s12032-014-0372-2↗
  8. High ROR2 expression in tumor cells and stroma is correlated with poor prognosis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/srep12991↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yiye Li · 2 shared papers, 2021–2024 · strength 0.32
  2. Guangjun Nie · 2 shared papers, 2021–2024 · strength 0.32
  3. Hongsheng Chen · 1 shared paper, 2024 · strength 0.24
  4. Weifeng Ding · 1 shared paper, 2024 · strength 0.24
  5. Jianfei Huang · 4 shared papers, 2015–2016 · strength 0.24
  6. Zhiqin Wang · 1 shared paper, 2024 · strength 0.20
  7. Bowen Wu · 1 shared paper, 2024 · strength 0.20
  8. Minqi Gu · 1 shared paper, 2021 · strength 0.15
  9. Xiaozheng Zhao · 1 shared paper, 2021 · strength 0.13
  10. Xiao Zhao · 1 shared paper, 2021 · strength 0.13
  11. Zhiwei Wang · 2 shared papers, 2015–2016 · strength 0.12
  12. Wei Wang · 1 shared paper, 2016 · strength 0.06
  13. Hui Zhao · 1 shared paper, 2016 · strength 0.06
  14. Shuijin Lian · 1 shared paper, 2016 · strength 0.06
  15. Wei Wang · 1 shared paper, 2016 · strength 0.06
  16. Zhiwei Peter Wang · 1 shared paper, 2016 · strength 0.06
  17. Qingqing Wang · 1 shared paper, 2015 · strength 0.06
  18. Wei Wang · 1 shared paper, 2015 · strength 0.05
  19. Zhiwei Wang · 1 shared paper, 2015 · strength 0.05
  20. Yuhua Lu · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.